Challenges in the diagnosis, treatment and management of asthma during COVID-19 pandemic

1Aishwarya G, Corbin P, Zahra Q, Stephanie T, Daniel F, Gautam G, et al. A comprehensive review of manifestations of novel corona-viruses in the context of deadly COVID-19 global pandemic. The American Journal of the Medical Sciences. 2020;360(1): 5–34.AishwaryaGCorbinPZahraQStephanieTDanielFGautamGA comprehensive review of manifestations of novel corona-viruses in the context of deadly COVID-19 global pandemicThe American Journal of the Medical Sciences2020360153410.1016/j.amjms.2020.05.006Search in Google Scholar

2Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11): 1061–1069.WangDHuBHuCZhuFLiuXZhangJClinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, ChinaJAMA2020323111061106910.1001/jama.2020.1585Search in Google Scholar

3Guan WJ, Ni ZY, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382:1708–1720.GuanWJNiZYHuYLiangW-HOuC-QHeJ-XClinical characteristics of coronavirus disease 2019 in ChinaThe New England Journal of Medicine20203821708172010.1056/NEJMoa2002032Search in Google Scholar

4Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223): 497–506.HuangCWangYLiXRenLZhaoJHuYClinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet20203951022349750610.1016/S0140-6736(20)30183-5Search in Google Scholar

5Sarioğlu N. Asthma and COVID-19: what do we know? Tuberk Toraks. 2020;68(2): 141–147.SarioğluNAsthma and COVID-19: what do we know?Tuberk Toraks202068214114710.5578/tt.69775Search in Google Scholar

6Bolin W, Ruobao L, Zhong L, Yan H. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7): 6049–6057.BolinWRuobaoLZhongLYanHDoes comorbidity increase the risk of patients with COVID-19: evidence from meta-analysisAging20201276049605710.18632/aging.103000Search in Google Scholar

7World Health Organization. Coronavirus disease (COVID-19). Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200921-weekly-epi-update-6.pdf?-sfvrsn=d9cf9496_6 [Accessed 19th September 2020].World Health OrganizationCoronavirus disease (COVID-19)Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200921-weekly-epi-update-6.pdf?-sfvrsn=d9cf9496_6 [Accessed 19th September 2020].Search in Google Scholar

8Reddy AP, Gupta MR. Management of asthma: the current US and European guidelines. Advances in Experimental Medicine and Biology. 2014;795: 81–103.ReddyAPGuptaMRManagement of asthma: the current US and European guidelinesAdvances in Experimental Medicine and Biology20147958110310.1007/978-1-4614-8603-9_6Search in Google Scholar

9Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Updated 2020.Global Initiative for AsthmaGlobal Strategy for Asthma Management and PreventionUpdated 2020.Search in Google Scholar

10Papi A, Brightling C, Pedersen SE, Reddel HK. Asthma. Lancet. 2018;391: 783–800.PapiABrightlingCPedersenSEReddelHKAsthmaLancet201839178380010.1016/S0140-6736(17)33311-1Search in Google Scholar

11Castillo JR, Peters SP, Busse WW. Asthma exacerbations: pathogenesis, prevention, and treatment. The Journal of Allergy and Clinical Immunology. 2017;5(4): 918–927.CastilloJRPetersSPBusseWWAsthma exacerbations: pathogenesis, prevention, and treatmentThe Journal of Allergy and Clinical Immunology20175491892710.1016/j.jaip.2017.05.001595072728689842Search in Google Scholar

12NHS England. Next steps on NHS response to COVID-19: Letter from Sir Simon Stevens and Amanda Pritchard. Available from: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/20200317-NHS-COVID-letter-FINAL.pdf [17th March 2020].NHS EnglandNext steps on NHS response to COVID-19: Letter from Sir Simon Stevens and Amanda PritchardAvailable from: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/20200317-NHS-COVID-letter-FINAL.pdf [17th March 2020].Search in Google Scholar

13Willan J, King AJ, Jeffery K, Bienz N. Challenges for NHS hospitals during covid-19 epidemic Healthcare workers need comprehensive support as every aspect of care is reorganised. BMJ. 2020;368: m1117.WillanJKingAJJefferyKBienzNChallenges for NHS hospitals during covid-19 epidemic Healthcare workers need comprehensive support as every aspect of care is reorganisedBMJ2020368m111710.1136/bmj.m111732198166Search in Google Scholar

14Sulindro A, Nguyen Q, Provenzano Da, Gharibo C, Soin A, Kohan L, et al. The technological impact of COVID-19 on the future of education and health care delivery. Pain Physician. 2020;23: S367–S380.SulindroANguyenQProvenzanoDaGhariboCSoinAKohanLThe technological impact of COVID-19 on the future of education and health care deliveryPain Physician202023S367S38010.36076/ppj.2020/23/S367Search in Google Scholar

15George I, Salna M, Kobsa S, Deroo S, Kriegel J, Kriegel D, et al. The rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a center at the epicenter. The Annals of Thoracic Surgery. 2020;110: 1108–1118.GeorgeISalnaMKobsaSDerooSKriegelJKriegelDThe rapid transformation of cardiac surgery practice in the coronavirus disease 2019 (COVID-19) pandemic: insights and clinical strategies from a center at the epicenterThe Annals of Thoracic Surgery20201101108111810.1016/j.athoracsur.2020.04.012730973332591132Search in Google Scholar

16Order of the Minister of Health no.753/2020 for the modification of the order of the minister of health no.555/2020 regarding the approval of the plan of measures for the preparation of hospitals in the context of the covid-19 corona-virus epidemic. Available from: https://www.cnscbt.ro/index.php/lex/1752-ordinul-nr-753-2020-pentru-modificarea-ordinului-ministrului-sanatatii-nr-555-2020-privind-aprobarea-planului-de-masuri-pentru-pregatirea-spitalelor-in-contextul-epidemiei-de-coronavirus-covid-19-a-li/file [Accessed 20th September 2020].Order of the Minister of Health no.753/2020 for the modification of the order of the minister of health no.555/2020 regarding the approval of the plan of measures for the preparation of hospitals in the context of the covid-19 corona-virus epidemicAvailable from: https://www.cnscbt.ro/index.php/lex/1752-ordinul-nr-753-2020-pentru-modificarea-ordinului-ministrului-sanatatii-nr-555-2020-privind-aprobarea-planului-de-masuri-pentru-pregatirea-spitalelor-in-contextul-epidemiei-de-coronavirus-covid-19-a-li/file [Accessed 20th September 2020].Search in Google Scholar

17Order of the Minister of Health no. 555 of April 3, 2020 on the approval of the Plan of measures for the preparation of hospitals in the context of the coronavirus epidemic COVID-19, of the List of hospitals providing medical care to patients tested positive for SARS-CoV-2 virus in phase I and phase II and a List of support hospitals for patients tested positive or suspected of having the SARS-CoV-2 virus. Available from: http://www.cnas.ro/cjastm/media/postFiles/Ordin%20555_2020.pdf [Accessed 20th September 2020].Order of the Minister of Health no. 555 of April 3, 2020 on the approval of the Plan of measures for the preparation of hospitals in the context of the coronavirus epidemic COVID-19, of the List of hospitals providing medical care to patients tested positive for SARS-CoV-2 virus in phase I and phase II and a List of support hospitals for patients tested positive or suspected of having the SARS-CoV-2 virusAvailable from: http://www.cnas.ro/cjastm/media/postFiles/Ordin%20555_2020.pdf [Accessed 20th September 2020].Search in Google Scholar

18Wark PAB, Ramsahai JM, Pathinayake P, Malik B, Bartlett NW. Respiratory viruses and asthma. Seminars in Respiratory and Critical Care Medicine. 2018;39: 45–55.WarkPABRamsahaiJMPathinayakePMalikBBartlettNWRespiratory viruses and asthmaSeminars in Respiratory and Critical Care Medicine201839455510.1055/s-0037-1617412711708629427985Search in Google Scholar

19Lu S, Hartert TV, Everard ML, Giezek H, Nelsen LM, Mehta A, et al. Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood. Pediatric Pulmonology. 2016;51(12): 1382–1392.LuSHartertTVEverardMLGiezekHNelsenLMMehtaAPredictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhoodPediatric Pulmonology201651121382139210.1002/ppul.23461666990127152482Search in Google Scholar

20Lee WM, Lemanske RF Jr, Evans MD, Vang F, Pappas T, Gangnon R, et al. Human rhinovirus species and season of infection determine illness severity. American Journal of Respiratory and Critical Care Medicine. 2012;186(9): 886–891.LeeWMLemanskeRFJrEvansMDVangFPappasTGangnonRHuman rhinovirus species and season of infection determine illness severityAmerican Journal of Respiratory and Critical Care Medicine2012186988689110.1164/rccm.201202-0330OC353021522923659Search in Google Scholar

21Johnston NW, Johnston SL, Duncan J, Greene JM, Kebadze T, Keith PK, et al. The September epidemic of asthma exacerbations in children: a search for etiology. The Journal of Allergy and Clinical Immunology. 2005;115(1): 132–138.JohnstonNWJohnstonSLDuncanJGreeneJMKebadzeTKeithPKThe September epidemic of asthma exacerbations in children: a search for etiologyThe Journal of Allergy and Clinical Immunology2005115113213810.1016/j.jaci.2004.09.025720245715637559Search in Google Scholar

22Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. The Journal of Allergy and Clinical Immunology. 2017;140(4): 895–906.JarttiTGernJERole of viral infections in the development and exacerbation of asthma in childrenThe Journal of Allergy and Clinical Immunology2017140489590610.1016/j.jaci.2017.08.003717281128987219Search in Google Scholar

23Jartti T, Bønnelykke K, Elenius V, Feleszko W. Role of viruses in asthma. Seminars in Immunopathology. 2020;42: 61–74.JarttiTBønnelykkeKEleniusVFeleszkoWRole of viruses in asthmaSeminars in Immunopathology202042617410.1007/s00281-020-00781-5706610131989228Search in Google Scholar

24Stein MM, Thompson EE, Schoettler N, Helling BA, Magnaye KM, Stanhope C, et al. A decade of research on the 17q12-21 asthma locus: piecing together the puzzle. The Journal of Allergy and Clinical Immunology. 2018;142(3): 749–764.SteinMMThompsonEESchoettlerNHellingBAMagnayeKMStanhopeCA decade of research on the 17q12-21 asthma locus: piecing together the puzzleThe Journal of Allergy and Clinical Immunology2018142374976410.1016/j.jaci.2017.12.974617203829307657Search in Google Scholar

25Bochkov YA, Watters K, Ashraf S, Griggs TF, Devries MK, Jackson DJ, et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proceedings of the National Academy of Sciences of the United States of America. 2015;112(17): 5485–5490.BochkovYAWattersKAshrafSGriggsTFDevriesMKJacksonDJCadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replicationProceedings of the National Academy of Sciences of the United States of America2015112175485549010.1073/pnas.1421178112441889025848009Search in Google Scholar

26Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. International Reviews of Immunology. 2011;30(1): 16–34.KumarHKawaiTAkiraSPathogen recognition by the innate immune systemInternational Reviews of Immunology2011301163410.3109/08830185.2010.52997621235323Search in Google Scholar

27Kumagai Y, Takeuchi O, Akira S. Pathogen recognition by innate receptors. Journal of Infection and Chemotherapy. 2008;14(2): 86–92.KumagaiYTakeuchiOAkiraSPathogen recognition by innate receptorsJournal of Infection and Chemotherapy2008142869210.1007/s10156-008-0596-118622669Search in Google Scholar

28Bowie AG, Haga IR. The role of toll-like receptors in the host response to viruses. Molecular Immunology. 2005;42(08): 859–867.BowieAGHagaIRThe role of toll-like receptors in the host response to virusesMolecular Immunology2005420885986710.1016/j.molimm.2004.11.00715829275Search in Google Scholar

29Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283: 499–505.GlezenWPGreenbergSBAtmarRLPiedraPACouchRBImpact of respiratory virus infections on persons with chronic underlying conditionsJAMA200028349950510.1001/jama.283.4.49910659876Search in Google Scholar

30Masatsugu O, Yuichi A, Takenori T, Tetsutaro S. Influenza A(H1N1)pdm09 virus and asthma. Frontiers in Microbiology. 2013;4: 307–312.MasatsuguOYuichiATakenoriTTetsutaroSInfluenza A(H1N1)pdm09 virus and asthmaFrontiers in Microbiology2013430731210.3389/fmicb.2013.00307Search in Google Scholar

31Kloepfer KM, Olenec JP, Lee WM, Liu G, Vrtis RF, Roberg KA, et al. Increased H1N1 infection rate in children with asthma. American Journal of Respiratory and Critical Care Medicine. 2012;185: 1275–1279.KloepferKMOlenecJPLeeWMLiuGVrtisRFRobergKAIncreased H1N1 infection rate in children with asthmaAmerican Journal of Respiratory and Critical Care Medicine20121851275127910.1164/rccm.201109-1635OC338123322366048Search in Google Scholar

32Yamaya M. Virus infectioninduced bronchial asthma exacerbation. Pulmonary Medicine. 2012;2012: 834826.YamayaMVirus infectioninduced bronchial asthma exacerbationPulmonary Medicine20122012:83482610.1155/2012/834826343254222966430Search in Google Scholar

33Veerapandian R, Snyder JD, Samarasinghe AE. Influenza in asthmatics: for better or for worse? Frontiers in Immunology. 2018;9: 1843.VeerapandianRSnyderJDSamarasingheAEInfluenza in asthmatics: for better or for worse?Frontiers in Immunology20189184310.3389/fimmu.2018.01843609598230147697Search in Google Scholar

34Kerkhove V, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Medicine. 2011;8: e1001053.KerkhoveVVandemaeleKAShindeVJaramillo-GutierrezGKoukounariADonnellyCARisk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysisPLoS Medicine20118e100105310.1371/journal.pmed.1001053313002121750667Search in Google Scholar

35Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG, et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009). Thorax. 2010;65: 645–651.Nguyen-Van-TamJSOpenshawPJHashimAGaddEMLimWSSempleMGRisk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)Thorax20106564565110.1136/thx.2010.135210292128720627925Search in Google Scholar

36Myles PR, Semple MG, Lim WS, Openshaw JM, Gadd EM, Read RC, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK. Thorax. 2012;67: 709–717.MylesPRSempleMGLimWSOpenshawJMGaddEMReadRCPredictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UKThorax20126770971710.1136/thoraxjnl-2011-200266340274922407890Search in Google Scholar

37Brun-Buisson C, Richard JC, Mercat A, Thiébaut CM, Brochard L; REVA-SRLF A/H1N1v 2009 registry group. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine. 2011;183: 1200–12006.Brun-BuissonCRichardJCMercatAThiébautCMBrochardLREVA-SRLF A/H1N1v 2009 registry groupEarly corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndromeAmerican Journal of Respiratory and Critical Care Medicine201118312001200610.1164/rccm.201101-0135OCSearch in Google Scholar

38Zhang Y, Sun WJ, Svendsen ER, Tang S, et al. Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis. Critical Care. 2015;19: 46.ZhangYSunWJSvendsenERTangSDo corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysisCritical Care2015194610.1186/s13054-015-0764-5Search in Google Scholar

39World Health Organization (WHO), 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=CjwKCAjwwab7BRBAEiwAapqpTKuKNANFo8ob-1Vu-a2jzaJWpFm8G1KhxdntVck5w4wdZM-7w7gpwXxoC-KIQAvD_BwE [Accessed 19th September 2020].World Health Organization (WHO)2020Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=CjwKCAjwwab7BRBAEiwAapqpTKuKNANFo8ob-1Vu-a2jzaJWpFm8G1KhxdntVck5w4wdZM-7w7gpwXxoC-KIQAvD_BwE [Accessed 19th September 2020].Search in Google Scholar

40Isidori AM, Arnaldi G, Boscaro M, Falomi A, Giordano C, Giordano C, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufciency. Journal of Endocrinological Investigation. 2020;43: 1141–1147.IsidoriAMArnaldiGBoscaroMFalomiAGiordanoCGiordanoCCOVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufciencyJournal of Endocrinological Investigation2020431141114710.1007/s40618-020-01266-wSearch in Google Scholar

41Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases. 2020;20(7): P773.BaudDQiXNielsen-SainesKMussoDPomarLFavreGReal estimates of mortality following COVID-19 infectionThe Lancet Infectious Diseases2020207P77310.1016/S1473-3099(20)30195-XSearch in Google Scholar

42Figueroa-Parra G, Aguirre-Garcia GM, Gamboa-Alonso CM, Camacho-Ortiz A, Galarza-Delgado. Are my patients with rheumatic diseases at higher risk of COVID-19? Annals of the Rheumatic Diseases. 2020;79: 839–840.Figueroa-ParraGAguirre-GarciaGMGamboa-AlonsoCMCamacho-OrtizAGalarza-DelgadoAre my patients with rheumatic diseases at higher risk of COVID-19?Annals of the Rheumatic Diseases20207983984010.1136/annrheumdis-2020-217322Search in Google Scholar

43Halpin DMG, Faner R, Sibila O, Badia JR, Agusti A. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? The Lancet Respiratory Medicine. 2020;8(5): P436–P438.HalpinDMGFanerRSibilaOBadiaJRAgustiADo chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?The Lancet Respiratory Medicine202085P436P43810.1016/S2213-2600(20)30167-3Search in Google Scholar

44Halpin DMG, Singh D, Hadfield RM. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. European Respiratory Journal. 2020;55: 2001009.HalpinDMGSinghDHadfieldRMInhaled corticosteroids and COVID-19: a systematic review and clinical perspectiveEuropean Respiratory Journal202055200100910.1183/13993003.01009-2020723682832341100Search in Google Scholar

45McKeever T, Harrison TW, Hubbard R, Shaw D. Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case–control study. Chest. 2013;144: 1788–1794.McKeeverTHarrisonTWHubbardRShawDInhaled corticosteroids and the risk of pneumonia in people with asthma: a case–control studyChest20131441788179410.1378/chest.13-087123990003Search in Google Scholar

46Johnston SL. Overview of virus-induced airway disease. Proceedings of the American Thoracic Society. 2005;2: 150–156.JohnstonSLOverview of virus-induced airway diseaseProceedings of the American Thoracic Society2005215015610.1513/pats.200502-018AW16113484Search in Google Scholar

47Mattos-Silvaa P, Felixa NS, Silva PL, Robba C, Battaglini D, Pelosi P. Pros and cons of corticosteroid therapy for COVID-19 patients. Respiratory Physiology & Neurobiology. 2020;280: 103492.Mattos-SilvaaPFelixaNSSilvaPLRobbaCBattagliniDPelosiPPros and cons of corticosteroid therapy for COVID-19 patientsRespiratory Physiology & Neurobiology202028010349210.1016/j.resp.2020.103492735105232659271Search in Google Scholar

48Bhimraj A, Morgan L, Shumaker AH, Lavergne V, Baden L, Cheng, VC-C, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19; 2020. Available form: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/ [Accessed 18th Septembre 2020].BhimrajAMorganLShumakerAHLavergneVBadenLChengVC-CInfectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-192020Available form: https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/ [Accessed 18th Septembre 2020].10.1093/cid/ciaa478719761232338708Search in Google Scholar

49Zhang S, Li D, Chen HZ, Zheng D, Zhou Y, Chen B, et al. Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids. Journal of Zhejiang University (Medical Science). 2020;49(2): 220–226.ZhangSLiDChenHZZhengDZhouYChenBDynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroidsJournal of Zhejiang University (Medical Science)2020492220226Search in Google Scholar

50Global Initiative for Asthma (GINA), Recommendations for inhaled asthma controller medications, Available from: https://ginasthma.org/recommendations-for-inhaled-asthma-controller-medications/ [Accessed 18th September 2020].Global Initiative for Asthma (GINA)Recommendations for inhaled asthma controller medicationsAvailable from: https://ginasthma.org/recommendations-for-inhaled-asthma-controller-medications/ [Accessed 18th September 2020].Search in Google Scholar

51American Lung Association, Asthma & COPD: CoViD-19 myth busting with Dr. Juanita Mora. Available from: https://www.lung.org/blog/covid-19-myth-busting [Accessed 18th September 2020].American Lung Association, Asthma & COPDCoViD-19 myth busting with Dr. Juanita MoraAvailable from: https://www.lung.org/blog/covid-19-myth-busting [Accessed 18th September 2020].Search in Google Scholar

52NICE Guideline, COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD). Available from: https://www.nice.org.uk/guidance/ng168/chapter/2-Treatment-and-care-planning [Accessed 18th September 2020].NICE GuidelineCOVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)Available from: https://www.nice.org.uk/guidance/ng168/chapter/2-Treatment-and-care-planning [Accessed 18th September 2020].Search in Google Scholar

53Morais-Almeidaa M, Aguiara R, Martin B, Ansotegui IJ, Ebisawa M, Karla Arruda L, et al. COVID-19, asthma, and biological therapies: What we need to know. World Allergy Organization Journal. 2020;13: 100126.Morais-AlmeidaaMAguiaraRMartinBAnsoteguiIJEbisawaMKarla ArrudaLCOVID-19, asthma, and biological therapies: What we need to knowWorld Allergy Organization Journal20201310012610.1016/j.waojou.2020.100126722995432426090Search in Google Scholar

54European Lung Foundation (ELF) recomandations. Available from: https://www.europeanlung.org/covid-19/covid-19-information-and-resources/covid-19-info [Accessed 19th September 2020].European Lung Foundation (ELF) recomandationsAvailable from: https://www.europeanlung.org/covid-19/covid-19-information-and-resources/covid-19-info [Accessed 19th September 2020].Search in Google Scholar

55Ministry of Health Pneumology Commission. Recommendations on the approach to respiratory diseases during the Covid-19 pandemic. Nr. 29/21; April 2020. Available from: http://www.ms.ro/wp-content/uploads/2020/04/Recomanda%CC%86ri-cu-privire-la-abordul-afect%CC%A6iunilor-respiratorii-pe-perioada-pandemiei-COVID-19.pdf [Accessed 19th September 2020].Ministry of Health Pneumology CommissionRecommendations on the approach to respiratory diseases during the Covid-19 pandemic. Nr. 29/21; April 2020Available from: http://www.ms.ro/wp-content/uploads/2020/04/Recomanda%CC%86ri-cu-privire-la-abordul-afect%CC%A6iunilor-respiratorii-pe-perioada-pandemiei-COVID-19.pdf [Accessed 19th September 2020].Search in Google Scholar